Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

There are always questions about our health and if you have or think you may have neuropathy, Dr. Kristen Ras-Davis, ...

Supplements are a popular choice for people with neuropathy, as they can help reduce pain and inflammation, improve nerve function, and promote overall health. However, with so many options on the ...

The active blisters lasted about three weeks. Since then, she’s been experiencing continued neuropathy that involves ...

Few studies have looked at CBD and nerve pain specifically. With neuropathy, CBD research is even more limited. Still, because CBD may have the potential to help with pain, there’s a chance it ...

- The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

Voters in Johnson County, Kansas have chosen to re-elect Republican candidate Steve Howe as their District Attorney in the 2024 general election. Howe will be taking on a fifth term as Johnson ...

Living with a chronic pain condition can make everyday tasks more challenging. For some people in Southern Utah dealing with ...

Dr. Joshua Logan, DC, BCN, founder of True North Health Center, is board-certified in neuropathy and has been awarded “Best Holistic Pain Management” in Colorado Springs. The ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...